

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.42066051 |
| 2 | positive regulation of B cell differentiation (GO:0045579) | 5.24830979 |
| 3 | protein localization to endosome (GO:0036010) | 5.18619200 |
| 4 | negative regulation of cell killing (GO:0031342) | 5.12129319 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.12129319 |
| 6 | purine nucleobase biosynthetic process (GO:0009113) | 4.72140014 |
| 7 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.64607601 |
| 8 | nucleobase biosynthetic process (GO:0046112) | 4.56544889 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.54253230 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.53455701 |
| 11 | mitotic metaphase plate congression (GO:0007080) | 4.50818100 |
| 12 | regulation of B cell differentiation (GO:0045577) | 4.23563334 |
| 13 | DNA strand elongation (GO:0022616) | 4.21103565 |
| 14 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.16685926 |
| 15 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.15597246 |
| 16 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.15047937 |
| 17 | DNA deamination (GO:0045006) | 4.03541832 |
| 18 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.95252453 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 3.90769963 |
| 20 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.89426477 |
| 21 | ribosome biogenesis (GO:0042254) | 3.83200487 |
| 22 | response to nerve growth factor (GO:1990089) | 3.82822173 |
| 23 | cellular response to nerve growth factor stimulus (GO:1990090) | 3.82822173 |
| 24 | telomere maintenance via recombination (GO:0000722) | 3.78978465 |
| 25 | regulation of gamma-delta T cell activation (GO:0046643) | 3.75828954 |
| 26 | formation of translation preinitiation complex (GO:0001731) | 3.73239454 |
| 27 | negative T cell selection (GO:0043383) | 3.71511919 |
| 28 | positive regulation of granulocyte differentiation (GO:0030854) | 3.69862649 |
| 29 | telomere maintenance via telomerase (GO:0007004) | 3.69449192 |
| 30 | DNA replication initiation (GO:0006270) | 3.68616920 |
| 31 | metaphase plate congression (GO:0051310) | 3.68419482 |
| 32 | telomere maintenance via telomere lengthening (GO:0010833) | 3.65210899 |
| 33 | immunoglobulin mediated immune response (GO:0016064) | 3.64151485 |
| 34 | ribosome assembly (GO:0042255) | 3.62796361 |
| 35 | DNA replication checkpoint (GO:0000076) | 3.62485335 |
| 36 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.60513995 |
| 37 | folic acid metabolic process (GO:0046655) | 3.60204210 |
| 38 | negative thymic T cell selection (GO:0045060) | 3.57355502 |
| 39 | ribosomal small subunit assembly (GO:0000028) | 3.55987936 |
| 40 | regulation of spindle organization (GO:0090224) | 3.51193954 |
| 41 | protein localization to kinetochore (GO:0034501) | 3.46427247 |
| 42 | mitotic recombination (GO:0006312) | 3.45537311 |
| 43 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.41852397 |
| 44 | B cell receptor signaling pathway (GO:0050853) | 3.40934682 |
| 45 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.40879444 |
| 46 | mitotic nuclear envelope disassembly (GO:0007077) | 3.40595046 |
| 47 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 3.40228239 |
| 48 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.38191352 |
| 49 | germ cell migration (GO:0008354) | 3.38147683 |
| 50 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.36867366 |
| 51 | establishment of chromosome localization (GO:0051303) | 3.31603279 |
| 52 | rRNA modification (GO:0000154) | 3.31148125 |
| 53 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.28245758 |
| 54 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.28113129 |
| 55 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.27938528 |
| 56 | actin nucleation (GO:0045010) | 3.26161858 |
| 57 | neutrophil activation (GO:0042119) | 3.24682439 |
| 58 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.24209974 |
| 59 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.23241144 |
| 60 | termination of RNA polymerase III transcription (GO:0006386) | 3.23241144 |
| 61 | snRNA processing (GO:0016180) | 3.22799740 |
| 62 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.22103833 |
| 63 | RNA-dependent DNA replication (GO:0006278) | 3.19045041 |
| 64 | nuclear envelope disassembly (GO:0051081) | 3.18768005 |
| 65 | membrane disassembly (GO:0030397) | 3.18768005 |
| 66 | nucleoside salvage (GO:0043174) | 3.18654475 |
| 67 | CENP-A containing nucleosome assembly (GO:0034080) | 3.18492905 |
| 68 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.17359195 |
| 69 | DNA replication-independent nucleosome organization (GO:0034724) | 3.17359195 |
| 70 | regulation of T cell tolerance induction (GO:0002664) | 3.15435958 |
| 71 | DNA-dependent DNA replication (GO:0006261) | 3.15275760 |
| 72 | negative regulation of type 2 immune response (GO:0002829) | 3.13768769 |
| 73 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.12658248 |
| 74 | response to interleukin-15 (GO:0070672) | 3.11937619 |
| 75 | regulation of tolerance induction (GO:0002643) | 3.10711696 |
| 76 | maturation of 5.8S rRNA (GO:0000460) | 3.07647054 |
| 77 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.07549031 |
| 78 | positive regulation of T cell cytokine production (GO:0002726) | 3.06941414 |
| 79 | IMP biosynthetic process (GO:0006188) | 3.05860787 |
| 80 | leukocyte degranulation (GO:0043299) | 3.05628236 |
| 81 | negative regulation of T cell mediated immunity (GO:0002710) | 3.05398956 |
| 82 | regulation of germinal center formation (GO:0002634) | 3.05270238 |
| 83 | mast cell activation (GO:0045576) | 3.03653920 |
| 84 | B cell mediated immunity (GO:0019724) | 3.03193660 |
| 85 | snRNA metabolic process (GO:0016073) | 3.03041783 |
| 86 | pyrimidine-containing compound salvage (GO:0008655) | 3.01996889 |
| 87 | pyrimidine nucleoside salvage (GO:0043097) | 3.01996889 |
| 88 | detection of other organism (GO:0098543) | 3.01624656 |
| 89 | detection of bacterium (GO:0016045) | 3.01557793 |
| 90 | chromatin remodeling at centromere (GO:0031055) | 3.01518601 |
| 91 | T cell migration (GO:0072678) | 3.01492990 |
| 92 | proteasome assembly (GO:0043248) | 3.01387684 |
| 93 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.00280049 |
| 94 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.99404230 |
| 95 | response to peptidoglycan (GO:0032494) | 2.98912993 |
| 96 | maturation of SSU-rRNA (GO:0030490) | 2.98856702 |
| 97 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.97613961 |
| 98 | definitive hemopoiesis (GO:0060216) | 2.97223772 |
| 99 | positive thymic T cell selection (GO:0045059) | 2.96188601 |
| 100 | rRNA methylation (GO:0031167) | 2.95882031 |
| 101 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.95845679 |
| 102 | viral mRNA export from host cell nucleus (GO:0046784) | 2.94894231 |
| 103 | regulation of mast cell degranulation (GO:0043304) | 2.93699428 |
| 104 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.92995204 |
| 105 | histone H3-K36 demethylation (GO:0070544) | 2.91738041 |
| 106 | cellular response to interleukin-15 (GO:0071350) | 2.90392527 |
| 107 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.90231623 |
| 108 | regulation of actin nucleation (GO:0051125) | 2.89819159 |
| 109 | protein localization to chromosome, centromeric region (GO:0071459) | 2.89661250 |
| 110 | positive T cell selection (GO:0043368) | 2.89417934 |
| 111 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.87856821 |
| 112 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.86088932 |
| 113 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.85859049 |
| 114 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.85452869 |
| 115 | UMP biosynthetic process (GO:0006222) | 2.85452869 |
| 116 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 2.85452869 |
| 117 | UMP metabolic process (GO:0046049) | 2.85452869 |
| 118 | mitochondrial DNA replication (GO:0006264) | 2.85413408 |
| 119 | DNA unwinding involved in DNA replication (GO:0006268) | 2.85091122 |
| 120 | positive regulation of interleukin-17 production (GO:0032740) | 2.84068799 |
| 121 | Peyers patch development (GO:0048541) | 2.84025845 |
| 122 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.84025845 |
| 123 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.84013283 |
| 124 | IMP metabolic process (GO:0046040) | 2.82511225 |
| 125 | granulocyte activation (GO:0036230) | 2.81178638 |
| 126 | telomere maintenance (GO:0000723) | 2.79053293 |
| 127 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.78868292 |
| 128 | telomere organization (GO:0032200) | 2.78313588 |
| 129 | leukocyte aggregation (GO:0070486) | 2.78186775 |
| 130 | negative regulation of chromosome segregation (GO:0051985) | 2.78068187 |
| 131 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.77106663 |
| 132 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.77106663 |
| 133 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.77106663 |
| 134 | negative regulation of sister chromatid segregation (GO:0033046) | 2.77106663 |
| 135 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.76986975 |
| 136 | positive regulation of mast cell degranulation (GO:0043306) | 2.76341024 |
| 137 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.76341024 |
| 138 | mitotic sister chromatid segregation (GO:0000070) | 2.76103487 |
| 139 | rRNA processing (GO:0006364) | 2.76065257 |
| 140 | regulation of translation in response to stress (GO:0043555) | 2.75441666 |
| 141 | spindle checkpoint (GO:0031577) | 2.75261109 |
| 142 | mitotic spindle assembly checkpoint (GO:0007094) | 2.75086013 |
| 143 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.74755768 |
| 144 | positive regulation of tolerance induction (GO:0002645) | 2.72124683 |
| 145 | spindle assembly checkpoint (GO:0071173) | 2.71484658 |
| 146 | regulation of mitotic spindle organization (GO:0060236) | 2.70902371 |
| 147 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.70608626 |
| 148 | regulation of mast cell activation (GO:0033003) | 2.70581681 |
| 149 | spliceosomal snRNP assembly (GO:0000387) | 2.70075005 |
| 150 | B cell homeostasis (GO:0001782) | 2.69279195 |
| 151 | regulation of hypersensitivity (GO:0002883) | 2.68852213 |
| 152 | T cell receptor signaling pathway (GO:0050852) | 2.68834016 |
| 153 | intracellular lipid transport (GO:0032365) | 2.68273406 |
| 154 | positive regulation of mast cell activation (GO:0033005) | 2.67565689 |
| 155 | mitotic chromosome condensation (GO:0007076) | 2.67267271 |
| 156 | rRNA metabolic process (GO:0016072) | 2.66089298 |
| 157 | folic acid transport (GO:0015884) | 2.65901368 |
| 158 | regulation of regulatory T cell differentiation (GO:0045589) | 2.65834651 |
| 159 | regulation of heat generation (GO:0031650) | 2.65651684 |
| 160 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.65413081 |
| 161 | mitotic spindle checkpoint (GO:0071174) | 2.65253870 |
| 162 | meiotic chromosome segregation (GO:0045132) | 2.65235674 |
| 163 | replication fork processing (GO:0031297) | 2.65160203 |
| 164 | positive regulation of interleukin-2 production (GO:0032743) | 2.65075080 |
| 165 | neutrophil mediated immunity (GO:0002446) | 2.64252706 |
| 166 | T cell selection (GO:0045058) | 2.63461108 |
| 167 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.62806713 |
| 168 | glycine metabolic process (GO:0006544) | 2.62591057 |
| 169 | protein deneddylation (GO:0000338) | 2.62368610 |
| 170 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.61472499 |
| 171 | germinal center formation (GO:0002467) | 2.61302992 |
| 172 | interferon-gamma production (GO:0032609) | 2.61256210 |
| 173 | 7-methylguanosine mRNA capping (GO:0006370) | 2.61188058 |
| 174 | mast cell activation involved in immune response (GO:0002279) | 2.61135903 |
| 175 | mast cell degranulation (GO:0043303) | 2.61135903 |
| 176 | regulation of chromosome segregation (GO:0051983) | 2.60768768 |
| 177 | T cell homeostasis (GO:0043029) | 2.59552079 |
| 178 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.57910186 |
| 179 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.57725749 |
| 180 | oxidative phosphorylation (GO:0006119) | 2.57162412 |
| 181 | myeloid cell activation involved in immune response (GO:0002275) | 2.56701058 |
| 182 | RNA capping (GO:0036260) | 2.56589264 |
| 183 | 7-methylguanosine RNA capping (GO:0009452) | 2.56589264 |
| 184 | nuclear envelope organization (GO:0006998) | 2.55138709 |
| 185 | negative regulation of T cell apoptotic process (GO:0070233) | 2.55121265 |
| 186 | lymphocyte homeostasis (GO:0002260) | 2.53430140 |
| 187 | regulation of T cell cytokine production (GO:0002724) | 2.52381495 |
| 188 | regulation of granulocyte differentiation (GO:0030852) | 2.51535518 |
| 189 | T cell costimulation (GO:0031295) | 2.50474787 |
| 190 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.49000110 |
| 191 | metallo-sulfur cluster assembly (GO:0031163) | 2.46449344 |
| 192 | iron-sulfur cluster assembly (GO:0016226) | 2.46449344 |
| 193 | lymphocyte costimulation (GO:0031294) | 2.46383365 |
| 194 | regulation of interleukin-17 production (GO:0032660) | 2.44840836 |
| 195 | negative regulation of adaptive immune response (GO:0002820) | 2.44791158 |
| 196 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.42792890 |
| 197 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.41380696 |
| 198 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.40860984 |
| 199 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.40783007 |
| 200 | negative regulation of B cell proliferation (GO:0030889) | 2.39787508 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.41567545 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.44921376 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.28451062 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.81294437 |
| 5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.58482824 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.32825759 |
| 7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.32507451 |
| 8 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.05885884 |
| 9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.98259482 |
| 10 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.89563995 |
| 11 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.87946535 |
| 12 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.73165836 |
| 13 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.71231222 |
| 14 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.70590121 |
| 15 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.70529436 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.64823124 |
| 17 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.63197201 |
| 18 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.62935248 |
| 19 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.53718895 |
| 20 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.38849868 |
| 21 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.34170656 |
| 22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.32506931 |
| 23 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.30821562 |
| 24 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.27474554 |
| 25 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.24100729 |
| 26 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.22567378 |
| 27 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.22318702 |
| 28 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.18612417 |
| 29 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.17744078 |
| 30 | MYB_26560356_Chip-Seq_TH1_Human | 2.12197703 |
| 31 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.12079125 |
| 32 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.09315091 |
| 33 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.08272516 |
| 34 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.05104404 |
| 35 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.04080137 |
| 36 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.04038020 |
| 37 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.03642055 |
| 38 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.01224306 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.00962644 |
| 40 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.96312421 |
| 41 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.96147701 |
| 42 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.96047080 |
| 43 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.96005686 |
| 44 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.94561241 |
| 45 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.93992063 |
| 46 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.89139384 |
| 47 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.88203140 |
| 48 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.86369682 |
| 49 | * MYC_22102868_ChIP-Seq_BL_Human | 1.85262234 |
| 50 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.83045260 |
| 51 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.77052671 |
| 52 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.76981609 |
| 53 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.74655112 |
| 54 | GATA3_26560356_Chip-Seq_TH2_Human | 1.73930185 |
| 55 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.73093250 |
| 56 | * POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.71723579 |
| 57 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.71139664 |
| 58 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70249227 |
| 59 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67716873 |
| 60 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.66984054 |
| 61 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.66855840 |
| 62 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.64721452 |
| 63 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64698976 |
| 64 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.64432099 |
| 65 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.62093502 |
| 66 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.61906994 |
| 67 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.61530113 |
| 68 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.60171697 |
| 69 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.60029754 |
| 70 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.59083121 |
| 71 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.55852710 |
| 72 | EWS_26573619_Chip-Seq_HEK293_Human | 1.55242491 |
| 73 | MAF_26560356_Chip-Seq_TH1_Human | 1.53638548 |
| 74 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.53042477 |
| 75 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.53013953 |
| 76 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.52354706 |
| 77 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.50533744 |
| 78 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.47647460 |
| 79 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.45761767 |
| 80 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.45460771 |
| 81 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.44790309 |
| 82 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.42193921 |
| 83 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.41416549 |
| 84 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.41353878 |
| 85 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.37983637 |
| 86 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.36103252 |
| 87 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.35470648 |
| 88 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.34959975 |
| 89 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.34891054 |
| 90 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.32682813 |
| 91 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.32476455 |
| 92 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.31531099 |
| 93 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.29532960 |
| 94 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.29432219 |
| 95 | UTX_26944678_Chip-Seq_JUKART_Human | 1.28767948 |
| 96 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.28629422 |
| 97 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.28152880 |
| 98 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.28133696 |
| 99 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.27328901 |
| 100 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.25851039 |
| 101 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.24863879 |
| 102 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.23425132 |
| 103 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.23183751 |
| 104 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.22778123 |
| 105 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.20879490 |
| 106 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.20178630 |
| 107 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.19802763 |
| 108 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.19475614 |
| 109 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16571211 |
| 110 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.15415531 |
| 111 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15402822 |
| 112 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.14684161 |
| 113 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.11815432 |
| 114 | GATA3_26560356_Chip-Seq_TH1_Human | 1.11364370 |
| 115 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.10880904 |
| 116 | FUS_26573619_Chip-Seq_HEK293_Human | 1.10768063 |
| 117 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.07529902 |
| 118 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.07312850 |
| 119 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.06962414 |
| 120 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06323958 |
| 121 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.05863884 |
| 122 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.04659885 |
| 123 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.03997338 |
| 124 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03825254 |
| 125 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.03376525 |
| 126 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.03353071 |
| 127 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.03336834 |
| 128 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.02519738 |
| 129 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.01465083 |
| 130 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01346010 |
| 131 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.94744661 |
| 132 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.93630894 |
| 133 | MAF_26560356_Chip-Seq_TH2_Human | 0.92765509 |
| 134 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92145765 |
| 135 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.91358986 |
| 136 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.91070236 |
| 137 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.90962206 |
| 138 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.90188875 |
| 139 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.89621095 |
| 140 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.89115585 |
| 141 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.89006369 |
| 142 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88701006 |
| 143 | GATA1_22025678_ChIP-Seq_K562_Human | 0.88116978 |
| 144 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.87796692 |
| 145 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.86733314 |
| 146 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.86710691 |
| 147 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.86456791 |
| 148 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.86090026 |
| 149 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.85798771 |
| 150 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.85423941 |
| 151 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.85360244 |
| 152 | * MYB_26560356_Chip-Seq_TH2_Human | 0.85202854 |
| 153 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.84734591 |
| 154 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83929244 |
| 155 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.83666997 |
| 156 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.82232890 |
| 157 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.81046044 |
| 158 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78901025 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.57061900 |
| 2 | MP0010094_abnormal_chromosome_stability | 4.02758021 |
| 3 | MP0003111_abnormal_nucleus_morphology | 3.62095948 |
| 4 | MP0004957_abnormal_blastocyst_morpholog | 3.56560303 |
| 5 | MP0003077_abnormal_cell_cycle | 3.46177402 |
| 6 | MP0002396_abnormal_hematopoietic_system | 3.24291344 |
| 7 | MP0008007_abnormal_cellular_replicative | 3.11633959 |
| 8 | MP0008058_abnormal_DNA_repair | 3.01740194 |
| 9 | MP0008057_abnormal_DNA_replication | 2.49201777 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 2.43905184 |
| 11 | MP0003303_peritoneal_inflammation | 2.29842953 |
| 12 | MP0006082_CNS_inflammation | 2.12328228 |
| 13 | MP0009278_abnormal_bone_marrow | 2.04189280 |
| 14 | MP0003718_maternal_effect | 2.00715126 |
| 15 | MP0009333_abnormal_splenocyte_physiolog | 1.99116790 |
| 16 | MP0009840_abnormal_foam_cell | 1.94654955 |
| 17 | MP0001790_abnormal_immune_system | 1.93057555 |
| 18 | MP0005387_immune_system_phenotype | 1.93057555 |
| 19 | MP0000350_abnormal_cell_proliferation | 1.80855956 |
| 20 | MP0001986_abnormal_taste_sensitivity | 1.79432001 |
| 21 | MP0009697_abnormal_copulation | 1.77284981 |
| 22 | MP0004808_abnormal_hematopoietic_stem | 1.75125592 |
| 23 | MP0000490_abnormal_crypts_of | 1.73847433 |
| 24 | MP0001730_embryonic_growth_arrest | 1.70728346 |
| 25 | MP0005397_hematopoietic_system_phenotyp | 1.68145112 |
| 26 | MP0001545_abnormal_hematopoietic_system | 1.68145112 |
| 27 | MP0005671_abnormal_response_to | 1.67319604 |
| 28 | MP0001835_abnormal_antigen_presentation | 1.65776660 |
| 29 | MP0008932_abnormal_embryonic_tissue | 1.64851509 |
| 30 | MP0003763_abnormal_thymus_physiology | 1.62198105 |
| 31 | MP0002398_abnormal_bone_marrow | 1.61471328 |
| 32 | MP0002139_abnormal_hepatobiliary_system | 1.57951083 |
| 33 | MP0003786_premature_aging | 1.57383964 |
| 34 | MP0002019_abnormal_tumor_incidence | 1.55135228 |
| 35 | MP0008877_abnormal_DNA_methylation | 1.54138599 |
| 36 | MP0003186_abnormal_redox_activity | 1.51277331 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.50566604 |
| 38 | MP0002722_abnormal_immune_system | 1.49021117 |
| 39 | MP0004782_abnormal_surfactant_physiolog | 1.48121076 |
| 40 | MP0009785_altered_susceptibility_to | 1.45753080 |
| 41 | MP0002009_preneoplasia | 1.44912145 |
| 42 | MP0004043_abnormal_pH_regulation | 1.39962770 |
| 43 | MP0002132_abnormal_respiratory_system | 1.39742321 |
| 44 | MP0006036_abnormal_mitochondrial_physio | 1.36767388 |
| 45 | MP0010307_abnormal_tumor_latency | 1.36360924 |
| 46 | MP0001697_abnormal_embryo_size | 1.36346015 |
| 47 | MP0002080_prenatal_lethality | 1.36105266 |
| 48 | MP0001764_abnormal_homeostasis | 1.36024560 |
| 49 | MP0002006_tumorigenesis | 1.33370713 |
| 50 | MP0003724_increased_susceptibility_to | 1.33130903 |
| 51 | MP0004484_altered_response_of | 1.32349589 |
| 52 | MP0005365_abnormal_bile_salt | 1.31082772 |
| 53 | MP0002166_altered_tumor_susceptibility | 1.30384443 |
| 54 | MP0003172_abnormal_lysosome_physiology | 1.30151392 |
| 55 | MP0001800_abnormal_humoral_immune | 1.29869859 |
| 56 | MP0003191_abnormal_cellular_cholesterol | 1.29423338 |
| 57 | MP0002429_abnormal_blood_cell | 1.28824223 |
| 58 | MP0000716_abnormal_immune_system | 1.27116717 |
| 59 | MP0010352_gastrointestinal_tract_polyps | 1.25464217 |
| 60 | MP0003567_abnormal_fetal_cardiomyocyte | 1.25429234 |
| 61 | MP0000313_abnormal_cell_death | 1.22938732 |
| 62 | MP0000685_abnormal_immune_system | 1.22936335 |
| 63 | MP0001672_abnormal_embryogenesis/_devel | 1.22898793 |
| 64 | MP0005380_embryogenesis_phenotype | 1.22898793 |
| 65 | MP0003123_paternal_imprinting | 1.21579889 |
| 66 | MP0000703_abnormal_thymus_morphology | 1.20856031 |
| 67 | MP0008995_early_reproductive_senescence | 1.16252664 |
| 68 | MP0002420_abnormal_adaptive_immunity | 1.14366896 |
| 69 | MP0002723_abnormal_immune_serum | 1.14127027 |
| 70 | MP0001819_abnormal_immune_cell | 1.13551994 |
| 71 | MP0000465_gastrointestinal_hemorrhage | 1.13457992 |
| 72 | MP0004947_skin_inflammation | 1.12466678 |
| 73 | MP0009764_decreased_sensitivity_to | 1.11282829 |
| 74 | MP0003984_embryonic_growth_retardation | 1.07593699 |
| 75 | MP0002452_abnormal_antigen_presenting | 1.06557431 |
| 76 | MP0005025_abnormal_response_to | 1.06392455 |
| 77 | MP0001873_stomach_inflammation | 1.05651666 |
| 78 | MP0000858_altered_metastatic_potential | 1.04818272 |
| 79 | MP0000358_abnormal_cell_content/ | 1.03901063 |
| 80 | MP0002088_abnormal_embryonic_growth/wei | 1.03312357 |
| 81 | MP0001119_abnormal_female_reproductive | 1.03054042 |
| 82 | MP0000598_abnormal_liver_morphology | 1.02067385 |
| 83 | MP0005084_abnormal_gallbladder_morpholo | 1.01194965 |
| 84 | MP0005464_abnormal_platelet_physiology | 1.01125449 |
| 85 | MP0002086_abnormal_extraembryonic_tissu | 1.01087192 |
| 86 | MP0010155_abnormal_intestine_physiology | 0.99459200 |
| 87 | MP0001533_abnormal_skeleton_physiology | 0.98859523 |
| 88 | MP0006035_abnormal_mitochondrial_morpho | 0.97948934 |
| 89 | MP0008260_abnormal_autophagy | 0.96581745 |
| 90 | MP0003866_abnormal_defecation | 0.96539642 |
| 91 | MP0000609_abnormal_liver_physiology | 0.95049076 |
| 92 | MP0003221_abnormal_cardiomyocyte_apopto | 0.94556054 |
| 93 | MP0003436_decreased_susceptibility_to | 0.94269001 |
| 94 | MP0003828_pulmonary_edema | 0.92475807 |
| 95 | MP0008004_abnormal_stomach_pH | 0.91915244 |
| 96 | MP0005310_abnormal_salivary_gland | 0.90520720 |
| 97 | MP0002405_respiratory_system_inflammati | 0.90242300 |
| 98 | MP0000681_abnormal_thyroid_gland | 0.90151620 |
| 99 | MP0005319_abnormal_enzyme/_coenzyme | 0.89545841 |
| 100 | MP0008469_abnormal_protein_level | 0.89420085 |
| 101 | MP0002085_abnormal_embryonic_tissue | 0.89124411 |
| 102 | MP0005000_abnormal_immune_tolerance | 0.88763557 |
| 103 | MP0005085_abnormal_gallbladder_physiolo | 0.88542396 |
| 104 | MP0001845_abnormal_inflammatory_respons | 0.86740974 |
| 105 | MP0002998_abnormal_bone_remodeling | 0.86296623 |
| 106 | MP0003656_abnormal_erythrocyte_physiolo | 0.85521874 |
| 107 | MP0005075_abnormal_melanosome_morpholog | 0.84951786 |
| 108 | MP0010329_abnormal_lipoprotein_level | 0.84544080 |
| 109 | MP0002419_abnormal_innate_immunity | 0.84539437 |
| 110 | MP0003943_abnormal_hepatobiliary_system | 0.80564842 |
| 111 | MP0004264_abnormal_extraembryonic_tissu | 0.80154609 |
| 112 | MP0002148_abnormal_hypersensitivity_rea | 0.80064560 |
| 113 | MP0005451_abnormal_body_composition | 0.78675341 |
| 114 | MP0002084_abnormal_developmental_patter | 0.77785507 |
| 115 | MP0009763_increased_sensitivity_to | 0.76842776 |
| 116 | MP0000569_abnormal_digit_pigmentation | 0.76170124 |
| 117 | MP0002095_abnormal_skin_pigmentation | 0.76082323 |
| 118 | MP0005384_cellular_phenotype | 0.75831700 |
| 119 | MP0001851_eye_inflammation | 0.75450994 |
| 120 | MP0001853_heart_inflammation | 0.75083065 |
| 121 | MP0005621_abnormal_cell_physiology | 0.74164910 |
| 122 | MP0000653_abnormal_sex_gland | 0.72169024 |
| 123 | MP0008873_increased_physiological_sensi | 0.71651387 |
| 124 | MP0001145_abnormal_male_reproductive | 0.70568367 |
| 125 | MP0002210_abnormal_sex_determination | 0.69832039 |
| 126 | MP0003448_altered_tumor_morphology | 0.69808413 |
| 127 | MP0005266_abnormal_metabolism | 0.69074155 |
| 128 | MP0002277_abnormal_respiratory_mucosa | 0.64978710 |
| 129 | MP0001929_abnormal_gametogenesis | 0.63670338 |
| 130 | MP0003300_gastrointestinal_ulcer | 0.62846769 |
| 131 | MP0002933_joint_inflammation | 0.61971170 |
| 132 | MP0002877_abnormal_melanocyte_morpholog | 0.60826216 |
| 133 | MP0004883_abnormal_blood_vessel | 0.59878912 |
| 134 | MP0009765_abnormal_xenobiotic_induced | 0.59096064 |
| 135 | MP0001191_abnormal_skin_condition | 0.59020295 |
| 136 | MP0000613_abnormal_salivary_gland | 0.58327384 |
| 137 | MP0001919_abnormal_reproductive_system | 0.57954860 |
| 138 | MP0001177_atelectasis | 0.57283099 |
| 139 | MP0005410_abnormal_fertilization | 0.56402601 |
| 140 | MP0008789_abnormal_olfactory_epithelium | 0.54271376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Birth length less than 3rd percentile (HP:0003561) | 5.04373182 |
| 2 | T lymphocytopenia (HP:0005403) | 4.75005942 |
| 3 | Abnormality of T cell number (HP:0011839) | 4.41693921 |
| 4 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.40015123 |
| 5 | Abnormality of B cell number (HP:0010975) | 4.21780370 |
| 6 | Severe combined immunodeficiency (HP:0004430) | 4.17450457 |
| 7 | B lymphocytopenia (HP:0010976) | 4.11899971 |
| 8 | Thrombocytosis (HP:0001894) | 3.98542942 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.67516994 |
| 10 | Recurrent fungal infections (HP:0002841) | 3.67477385 |
| 11 | Recurrent viral infections (HP:0004429) | 3.59995799 |
| 12 | Microretrognathia (HP:0000308) | 3.56592265 |
| 13 | Stomatitis (HP:0010280) | 3.54187576 |
| 14 | Aplastic anemia (HP:0001915) | 3.53261067 |
| 15 | Combined immunodeficiency (HP:0005387) | 3.45237083 |
| 16 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.44260135 |
| 17 | Recurrent cutaneous fungal infections (HP:0011370) | 3.44260135 |
| 18 | Abnormality of the anterior horn cell (HP:0006802) | 3.41803317 |
| 19 | Degeneration of anterior horn cells (HP:0002398) | 3.41803317 |
| 20 | Capillary hemangiomas (HP:0005306) | 3.40670594 |
| 21 | Amyotrophic lateral sclerosis (HP:0007354) | 3.35058201 |
| 22 | Eosinophilia (HP:0001880) | 3.35015386 |
| 23 | Granulocytopenia (HP:0001913) | 3.33092437 |
| 24 | Agammaglobulinemia (HP:0004432) | 3.32345585 |
| 25 | Meningitis (HP:0001287) | 3.30145533 |
| 26 | Encephalitis (HP:0002383) | 3.28369490 |
| 27 | Abnormality of eosinophils (HP:0001879) | 3.21249850 |
| 28 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.19959753 |
| 29 | Rough bone trabeculation (HP:0100670) | 3.19808101 |
| 30 | Breast hypoplasia (HP:0003187) | 3.04544183 |
| 31 | Oral leukoplakia (HP:0002745) | 3.03141399 |
| 32 | Eczematoid dermatitis (HP:0000976) | 3.00426081 |
| 33 | Posterior subcapsular cataract (HP:0007787) | 2.98359738 |
| 34 | Chest pain (HP:0100749) | 2.81677689 |
| 35 | Thyroiditis (HP:0100646) | 2.80682483 |
| 36 | Retrobulbar optic neuritis (HP:0100654) | 2.78942827 |
| 37 | Optic neuritis (HP:0100653) | 2.78942827 |
| 38 | Inflammation of the large intestine (HP:0002037) | 2.78941447 |
| 39 | Carpal bone hypoplasia (HP:0001498) | 2.78737090 |
| 40 | Leukocytosis (HP:0001974) | 2.77652820 |
| 41 | Recurrent skin infections (HP:0001581) | 2.77549202 |
| 42 | Abnormality of the prostate (HP:0008775) | 2.73453892 |
| 43 | Myositis (HP:0100614) | 2.71516826 |
| 44 | Patellar aplasia (HP:0006443) | 2.70172566 |
| 45 | Bone marrow hypocellularity (HP:0005528) | 2.69281385 |
| 46 | Obstructive lung disease (HP:0006536) | 2.67804480 |
| 47 | Chronic obstructive pulmonary disease (HP:0006510) | 2.67804480 |
| 48 | Hypoplasia of the thymus (HP:0000778) | 2.66764980 |
| 49 | IgM deficiency (HP:0002850) | 2.66665465 |
| 50 | Long nose (HP:0003189) | 2.66462808 |
| 51 | Gastrointestinal inflammation (HP:0004386) | 2.65905947 |
| 52 | Pustule (HP:0200039) | 2.63635284 |
| 53 | Orchitis (HP:0100796) | 2.61265807 |
| 54 | Mediastinal lymphadenopathy (HP:0100721) | 2.59025397 |
| 55 | Facial hemangioma (HP:0000329) | 2.58145699 |
| 56 | Colon cancer (HP:0003003) | 2.57570700 |
| 57 | Vasculitis (HP:0002633) | 2.56607658 |
| 58 | Myelodysplasia (HP:0002863) | 2.56176067 |
| 59 | Hypoproteinemia (HP:0003075) | 2.55317323 |
| 60 | Stomach cancer (HP:0012126) | 2.54904092 |
| 61 | Progressive inability to walk (HP:0002505) | 2.54457273 |
| 62 | Impulsivity (HP:0100710) | 2.53799581 |
| 63 | Gingival bleeding (HP:0000225) | 2.53249706 |
| 64 | Autoimmune hemolytic anemia (HP:0001890) | 2.52485778 |
| 65 | Keratoconjunctivitis sicca (HP:0001097) | 2.51709832 |
| 66 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.51146239 |
| 67 | Neoplasm of the pancreas (HP:0002894) | 2.49510467 |
| 68 | Pancreatic cysts (HP:0001737) | 2.48405318 |
| 69 | Keratoconjunctivitis (HP:0001096) | 2.47997694 |
| 70 | Hyperglycinemia (HP:0002154) | 2.46501254 |
| 71 | Cerebral hypomyelination (HP:0006808) | 2.41690559 |
| 72 | Type I transferrin isoform profile (HP:0003642) | 2.40738483 |
| 73 | Urticaria (HP:0001025) | 2.40735442 |
| 74 | Abnormality of macrophages (HP:0004311) | 2.36528501 |
| 75 | Reduced antithrombin III activity (HP:0001976) | 2.34796499 |
| 76 | Chromsome breakage (HP:0040012) | 2.34326683 |
| 77 | Abnormality of the pleura (HP:0002103) | 2.33114253 |
| 78 | Prolonged bleeding time (HP:0003010) | 2.32391854 |
| 79 | Epistaxis (HP:0000421) | 2.32143124 |
| 80 | Pulmonary infiltrates (HP:0002113) | 2.32078296 |
| 81 | Gastrointestinal infarctions (HP:0005244) | 2.31216130 |
| 82 | Type 2 muscle fiber atrophy (HP:0003554) | 2.31137769 |
| 83 | Increased IgM level (HP:0003496) | 2.28686341 |
| 84 | Amaurosis fugax (HP:0100576) | 2.28455337 |
| 85 | Alveolar cell carcinoma (HP:0006519) | 2.28339569 |
| 86 | Abnormality of the intrinsic pathway (HP:0010989) | 2.25689347 |
| 87 | Cellular immunodeficiency (HP:0005374) | 2.23403694 |
| 88 | Muscle fiber atrophy (HP:0100295) | 2.22135503 |
| 89 | Abnormal trabecular bone morphology (HP:0100671) | 2.20169135 |
| 90 | Premature graying of hair (HP:0002216) | 2.20140069 |
| 91 | Abnormal number of erythroid precursors (HP:0012131) | 2.18931845 |
| 92 | Multiple enchondromatosis (HP:0005701) | 2.18798837 |
| 93 | Lymphoma (HP:0002665) | 2.18725502 |
| 94 | Attenuation of retinal blood vessels (HP:0007843) | 2.16290740 |
| 95 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.15980501 |
| 96 | Selective tooth agenesis (HP:0001592) | 2.15909523 |
| 97 | Basal cell carcinoma (HP:0002671) | 2.15749567 |
| 98 | Viral hepatitis (HP:0006562) | 2.14369845 |
| 99 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.11895552 |
| 100 | 11 pairs of ribs (HP:0000878) | 2.11018606 |
| 101 | Pancytopenia (HP:0001876) | 2.10379402 |
| 102 | Hemoptysis (HP:0002105) | 2.09225532 |
| 103 | Entropion (HP:0000621) | 2.07504047 |
| 104 | Neoplasm of the oral cavity (HP:0100649) | 2.06760540 |
| 105 | Agnosia (HP:0010524) | 2.04738599 |
| 106 | Abnormality of T cell physiology (HP:0011840) | 2.04418882 |
| 107 | Spontaneous hematomas (HP:0007420) | 2.03383774 |
| 108 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.03015413 |
| 109 | Recurrent bacterial skin infections (HP:0005406) | 2.02200409 |
| 110 | Secondary amenorrhea (HP:0000869) | 2.01427511 |
| 111 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.01363685 |
| 112 | Reticulocytopenia (HP:0001896) | 2.01253145 |
| 113 | Conical tooth (HP:0000698) | 1.98525067 |
| 114 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.98292608 |
| 115 | IgG deficiency (HP:0004315) | 1.97750090 |
| 116 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.96943253 |
| 117 | Abnormality of lateral ventricle (HP:0030047) | 1.96930772 |
| 118 | Hypochromic microcytic anemia (HP:0004840) | 1.95028219 |
| 119 | Acute lymphatic leukemia (HP:0006721) | 1.94924318 |
| 120 | Lymphopenia (HP:0001888) | 1.94672029 |
| 121 | Colitis (HP:0002583) | 1.94546959 |
| 122 | Death in infancy (HP:0001522) | 1.94029288 |
| 123 | Abnormality of serum amino acid levels (HP:0003112) | 1.93406389 |
| 124 | Polycythemia (HP:0001901) | 1.92736671 |
| 125 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.92216467 |
| 126 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.92216467 |
| 127 | Chronic diarrhea (HP:0002028) | 1.90915413 |
| 128 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.90436313 |
| 129 | Dyschromatopsia (HP:0007641) | 1.90175111 |
| 130 | Abnormality of T cells (HP:0002843) | 1.89897391 |
| 131 | Abnormality of chromosome stability (HP:0003220) | 1.89120813 |
| 132 | Progressive muscle weakness (HP:0003323) | 1.89081505 |
| 133 | Renal cortical cysts (HP:0000803) | 1.88951365 |
| 134 | Metaphyseal dysplasia (HP:0100255) | 1.87730353 |
| 135 | Petechiae (HP:0000967) | 1.86471390 |
| 136 | Spontaneous abortion (HP:0005268) | 1.86112227 |
| 137 | Poikiloderma (HP:0001029) | 1.85849128 |
| 138 | Hyperglycinuria (HP:0003108) | 1.85806302 |
| 139 | Premature ovarian failure (HP:0008209) | 1.84652283 |
| 140 | Abnormality of macular pigmentation (HP:0008002) | 1.82895269 |
| 141 | Abnormal neuron morphology (HP:0012757) | 1.82689498 |
| 142 | Abnormality of the motor neurons (HP:0002450) | 1.82689498 |
| 143 | Papillary thyroid carcinoma (HP:0002895) | 1.82512713 |
| 144 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.81548031 |
| 145 | Sepsis (HP:0100806) | 1.81203537 |
| 146 | Broad alveolar ridges (HP:0000187) | 1.79855217 |
| 147 | Acute myeloid leukemia (HP:0004808) | 1.79440339 |
| 148 | Broad-based gait (HP:0002136) | 1.79286466 |
| 149 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.79114885 |
| 150 | Tinnitus (HP:0000360) | 1.79003163 |
| 151 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.77759769 |
| 152 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.77579355 |
| 153 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.77579355 |
| 154 | Abnormal protein glycosylation (HP:0012346) | 1.77579355 |
| 155 | Abnormal glycosylation (HP:0012345) | 1.77579355 |
| 156 | Broad palm (HP:0001169) | 1.77515648 |
| 157 | Recurrent abscess formation (HP:0002722) | 1.77328518 |
| 158 | Premature loss of primary teeth (HP:0006323) | 1.75350813 |
| 159 | CNS hypomyelination (HP:0003429) | 1.74940999 |
| 160 | Hypobetalipoproteinemia (HP:0003563) | 1.74486309 |
| 161 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.73903648 |
| 162 | Abnormality of the preputium (HP:0100587) | 1.73844699 |
| 163 | Ependymoma (HP:0002888) | 1.73503409 |
| 164 | Pulmonary embolism (HP:0002204) | 1.72366989 |
| 165 | Ragged-red muscle fibers (HP:0003200) | 1.71967839 |
| 166 | Hypoplasia of the pons (HP:0012110) | 1.71845498 |
| 167 | Hepatosplenomegaly (HP:0001433) | 1.71819299 |
| 168 | Joint swelling (HP:0001386) | 1.70290001 |
| 169 | Teleangiectasia of the skin (HP:0100585) | 1.70068169 |
| 170 | Panhypogammaglobulinemia (HP:0003139) | 1.69661629 |
| 171 | Sloping forehead (HP:0000340) | 1.68841060 |
| 172 | Abnormality of alanine metabolism (HP:0010916) | 1.68526223 |
| 173 | Hyperalaninemia (HP:0003348) | 1.68526223 |
| 174 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.68526223 |
| 175 | Hepatic necrosis (HP:0002605) | 1.68219290 |
| 176 | Increased serum lactate (HP:0002151) | 1.67524405 |
| 177 | Upper motor neuron abnormality (HP:0002127) | 1.67489997 |
| 178 | Abnormal lung lobation (HP:0002101) | 1.66986695 |
| 179 | Megaloblastic anemia (HP:0001889) | 1.66406042 |
| 180 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.65692912 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.47991383 |
| 2 | TAOK3 | 3.96666119 |
| 3 | BCR | 3.36545884 |
| 4 | WEE1 | 3.26534981 |
| 5 | CDK19 | 2.89909528 |
| 6 | PLK4 | 2.62798670 |
| 7 | TSSK6 | 2.57252611 |
| 8 | EIF2AK1 | 2.53026368 |
| 9 | RIPK4 | 2.49690452 |
| 10 | CDC7 | 2.35679714 |
| 11 | NEK2 | 2.35390127 |
| 12 | GRK6 | 2.26892005 |
| 13 | BRSK2 | 2.26617733 |
| 14 | FLT3 | 2.25797824 |
| 15 | EIF2AK3 | 2.22697079 |
| 16 | MAP3K14 | 2.20206671 |
| 17 | MAP3K13 | 2.15061544 |
| 18 | HCK | 2.03371747 |
| 19 | NME2 | 2.01688789 |
| 20 | NEK1 | 1.93286755 |
| 21 | FES | 1.90841354 |
| 22 | TESK2 | 1.87710024 |
| 23 | ERBB3 | 1.87019817 |
| 24 | CCNB1 | 1.80129442 |
| 25 | ITK | 1.79107404 |
| 26 | MAP2K3 | 1.78599390 |
| 27 | PLK1 | 1.76953898 |
| 28 | TTK | 1.74565677 |
| 29 | STK16 | 1.72128415 |
| 30 | VRK1 | 1.68707546 |
| 31 | PIM2 | 1.68203047 |
| 32 | MAP4K1 | 1.67086869 |
| 33 | IKBKE | 1.66436504 |
| 34 | BMPR2 | 1.65642762 |
| 35 | TGFBR1 | 1.64196936 |
| 36 | DYRK3 | 1.63175781 |
| 37 | ACVR1B | 1.61796132 |
| 38 | SIK3 | 1.57237965 |
| 39 | PASK | 1.53606632 |
| 40 | IRAK4 | 1.48749934 |
| 41 | PLK3 | 1.47278807 |
| 42 | BRSK1 | 1.46758848 |
| 43 | KIT | 1.46748250 |
| 44 | BCKDK | 1.45619540 |
| 45 | EEF2K | 1.42803337 |
| 46 | SCYL2 | 1.41896672 |
| 47 | TRIM28 | 1.39245551 |
| 48 | TNK2 | 1.38620942 |
| 49 | SRPK1 | 1.37845549 |
| 50 | CAMKK2 | 1.36290738 |
| 51 | CDK3 | 1.34971136 |
| 52 | MAP4K2 | 1.30501606 |
| 53 | ZAK | 1.30324917 |
| 54 | CSK | 1.26162738 |
| 55 | AURKB | 1.25703407 |
| 56 | RPS6KA4 | 1.25673045 |
| 57 | RPS6KB2 | 1.24262991 |
| 58 | TYK2 | 1.22621489 |
| 59 | CHEK2 | 1.19495339 |
| 60 | CDC42BPA | 1.18324208 |
| 61 | CSF1R | 1.13330106 |
| 62 | BTK | 1.13176029 |
| 63 | MATK | 1.11885033 |
| 64 | CDK7 | 1.09948331 |
| 65 | ZAP70 | 1.08693180 |
| 66 | ATR | 1.08577881 |
| 67 | CDK4 | 1.05480882 |
| 68 | TEC | 1.04675207 |
| 69 | BRAF | 1.03870059 |
| 70 | STK10 | 1.02963473 |
| 71 | MKNK1 | 1.02727534 |
| 72 | TLK1 | 0.99325871 |
| 73 | MKNK2 | 0.99284542 |
| 74 | KDR | 0.98604801 |
| 75 | PIM1 | 0.93151450 |
| 76 | AURKA | 0.92793178 |
| 77 | MAP3K6 | 0.89291524 |
| 78 | PAK4 | 0.88273725 |
| 79 | JAK3 | 0.86424357 |
| 80 | TXK | 0.84398160 |
| 81 | IKBKB | 0.83984171 |
| 82 | TBK1 | 0.83518914 |
| 83 | MAPKAPK3 | 0.83228349 |
| 84 | MAPK11 | 0.81312469 |
| 85 | CDK8 | 0.81195489 |
| 86 | SIK2 | 0.80984202 |
| 87 | CLK1 | 0.80982943 |
| 88 | STK3 | 0.80041620 |
| 89 | YES1 | 0.79902801 |
| 90 | IRAK2 | 0.79645993 |
| 91 | MAP3K8 | 0.78922226 |
| 92 | NLK | 0.77350217 |
| 93 | ARAF | 0.77253079 |
| 94 | CSNK1G2 | 0.75436087 |
| 95 | FGR | 0.74974067 |
| 96 | ABL1 | 0.74051775 |
| 97 | TAOK1 | 0.73055782 |
| 98 | CSNK1G3 | 0.72101818 |
| 99 | AKT3 | 0.71894719 |
| 100 | JAK2 | 0.71042822 |
| 101 | DYRK2 | 0.69703272 |
| 102 | TNIK | 0.68154543 |
| 103 | PRKCI | 0.67701079 |
| 104 | IRAK1 | 0.65655588 |
| 105 | PRKCQ | 0.65170684 |
| 106 | BLK | 0.64780360 |
| 107 | MAPK7 | 0.62847526 |
| 108 | STK38L | 0.61411347 |
| 109 | TIE1 | 0.60881217 |
| 110 | CHEK1 | 0.60144777 |
| 111 | CSNK1A1L | 0.59398942 |
| 112 | MAP3K4 | 0.57255758 |
| 113 | FGFR4 | 0.56257337 |
| 114 | MAP3K11 | 0.55610301 |
| 115 | EGFR | 0.54055892 |
| 116 | MAPK13 | 0.53999141 |
| 117 | CHUK | 0.53623026 |
| 118 | STK4 | 0.52730743 |
| 119 | RAF1 | 0.51760658 |
| 120 | CSNK2A1 | 0.51361920 |
| 121 | MAP3K5 | 0.50986256 |
| 122 | MAP3K3 | 0.50323375 |
| 123 | TGFBR2 | 0.50061217 |
| 124 | BRD4 | 0.48452723 |
| 125 | DYRK1B | 0.48422383 |
| 126 | LCK | 0.47794908 |
| 127 | SYK | 0.47694732 |
| 128 | EPHA2 | 0.47463728 |
| 129 | CDK2 | 0.46915023 |
| 130 | STK24 | 0.46510672 |
| 131 | JAK1 | 0.46156367 |
| 132 | IGF1R | 0.45699940 |
| 133 | CDK6 | 0.44987331 |
| 134 | CSNK2A2 | 0.44627628 |
| 135 | LYN | 0.44060865 |
| 136 | MELK | 0.43951822 |
| 137 | CSNK1G1 | 0.43819122 |
| 138 | EIF2AK2 | 0.43505947 |
| 139 | FYN | 0.43145312 |
| 140 | PKN2 | 0.41416230 |
| 141 | GRK1 | 0.40853752 |
| 142 | RPS6KA5 | 0.39967481 |
| 143 | RPS6KC1 | 0.39322456 |
| 144 | RPS6KL1 | 0.39322456 |
| 145 | RPS6KA6 | 0.36977279 |
| 146 | PAK1 | 0.36382742 |
| 147 | MAP3K7 | 0.35968405 |
| 148 | PDK1 | 0.35591699 |
| 149 | ERN1 | 0.35488152 |
| 150 | NUAK1 | 0.35475691 |
| 151 | EPHA3 | 0.35353420 |
| 152 | LATS1 | 0.34181198 |
| 153 | MARK3 | 0.34180608 |
| 154 | RPS6KB1 | 0.32678509 |
| 155 | OXSR1 | 0.29609252 |
| 156 | PIK3CG | 0.29188442 |
| 157 | CAMKK1 | 0.27395237 |
| 158 | ATM | 0.26480047 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.37375950 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 3.84304870 |
| 3 | RNA polymerase_Homo sapiens_hsa03020 | 3.22837188 |
| 4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.18802678 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.99615986 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.95748797 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.91823059 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 2.87096617 |
| 9 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.79694037 |
| 10 | Proteasome_Homo sapiens_hsa03050 | 2.65866594 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.63945398 |
| 12 | Asthma_Homo sapiens_hsa05310 | 2.60135301 |
| 13 | RNA transport_Homo sapiens_hsa03013 | 2.48961373 |
| 14 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.43356826 |
| 15 | Spliceosome_Homo sapiens_hsa03040 | 2.34609465 |
| 16 | Homologous recombination_Homo sapiens_hsa03440 | 2.34431579 |
| 17 | Cell cycle_Homo sapiens_hsa04110 | 2.29230186 |
| 18 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.13382426 |
| 19 | Ribosome_Homo sapiens_hsa03010 | 2.10695683 |
| 20 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.00738745 |
| 21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.99265761 |
| 22 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.97676841 |
| 23 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.94948864 |
| 24 | Viral myocarditis_Homo sapiens_hsa05416 | 1.82635868 |
| 25 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.80824163 |
| 26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.78375728 |
| 27 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.77780783 |
| 28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.76043519 |
| 29 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.69037201 |
| 30 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.65837246 |
| 31 | * RNA degradation_Homo sapiens_hsa03018 | 1.60807707 |
| 32 | Tuberculosis_Homo sapiens_hsa05152 | 1.59823825 |
| 33 | Basal transcription factors_Homo sapiens_hsa03022 | 1.48461049 |
| 34 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.47628775 |
| 35 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.42230645 |
| 36 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.42209684 |
| 37 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.41557192 |
| 38 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.34453231 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.33637485 |
| 40 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.28964811 |
| 41 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.26059194 |
| 42 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.24541003 |
| 43 | Purine metabolism_Homo sapiens_hsa00230 | 1.21940235 |
| 44 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.21341493 |
| 45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.19454336 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.18742007 |
| 47 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.15154447 |
| 48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.15019556 |
| 49 | Sulfur relay system_Homo sapiens_hsa04122 | 1.14693326 |
| 50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.12863585 |
| 51 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.12197726 |
| 52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.11439558 |
| 53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.10657855 |
| 54 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.09888466 |
| 55 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.09310474 |
| 56 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.04321209 |
| 57 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.91622742 |
| 58 | Measles_Homo sapiens_hsa05162 | 0.86506265 |
| 59 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.86144180 |
| 60 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.85999370 |
| 61 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.84589701 |
| 62 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.83358828 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 0.82647586 |
| 64 | Legionellosis_Homo sapiens_hsa05134 | 0.81231146 |
| 65 | Protein export_Homo sapiens_hsa03060 | 0.81145581 |
| 66 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.79588400 |
| 67 | Malaria_Homo sapiens_hsa05144 | 0.79359813 |
| 68 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79021952 |
| 69 | Salmonella infection_Homo sapiens_hsa05132 | 0.77815630 |
| 70 | Phagosome_Homo sapiens_hsa04145 | 0.77470032 |
| 71 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.75830019 |
| 72 | Pertussis_Homo sapiens_hsa05133 | 0.74617365 |
| 73 | Carbon metabolism_Homo sapiens_hsa01200 | 0.73944490 |
| 74 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.70261309 |
| 75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.70006434 |
| 76 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.69667081 |
| 77 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69368286 |
| 78 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.68639059 |
| 79 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.67216698 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64522569 |
| 81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.64318850 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.61601367 |
| 83 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.60300140 |
| 84 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.59870121 |
| 85 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.59667238 |
| 86 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59645475 |
| 87 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.59377965 |
| 88 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.57279751 |
| 89 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56718136 |
| 90 | Thyroid cancer_Homo sapiens_hsa05216 | 0.55426003 |
| 91 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.54657734 |
| 92 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.54142594 |
| 93 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.52823853 |
| 94 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.52602791 |
| 95 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.52433109 |
| 96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.51907523 |
| 97 | Influenza A_Homo sapiens_hsa05164 | 0.50606493 |
| 98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50588483 |
| 99 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50093372 |
| 100 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.49978754 |
| 101 | Colorectal cancer_Homo sapiens_hsa05210 | 0.48953463 |
| 102 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.48820706 |
| 103 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48728093 |
| 104 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.48208628 |
| 105 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47454834 |
| 106 | Leishmaniasis_Homo sapiens_hsa05140 | 0.45981917 |
| 107 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.45500394 |
| 108 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.45163894 |
| 109 | Peroxisome_Homo sapiens_hsa04146 | 0.44699044 |
| 110 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.44619542 |
| 111 | Shigellosis_Homo sapiens_hsa05131 | 0.44106932 |
| 112 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.43201872 |
| 113 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.42553307 |
| 114 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.42002955 |
| 115 | Lysosome_Homo sapiens_hsa04142 | 0.41890494 |
| 116 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.40771710 |
| 117 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.40602261 |
| 118 | Hepatitis B_Homo sapiens_hsa05161 | 0.38608349 |
| 119 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.38351986 |
| 120 | Apoptosis_Homo sapiens_hsa04210 | 0.38087044 |
| 121 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.37913963 |
| 122 | Taste transduction_Homo sapiens_hsa04742 | 0.37732199 |
| 123 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.37530482 |
| 124 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.36545860 |
| 125 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35578869 |
| 126 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35520094 |
| 127 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.34975796 |
| 128 | Olfactory transduction_Homo sapiens_hsa04740 | 0.34828469 |
| 129 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.34735064 |
| 130 | Retinol metabolism_Homo sapiens_hsa00830 | 0.34706124 |
| 131 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.34668751 |
| 132 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.34226210 |
| 133 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34186838 |
| 134 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.33109110 |
| 135 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.31241564 |
| 136 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.30576179 |
| 137 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.29997896 |
| 138 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29885621 |
| 139 | Phototransduction_Homo sapiens_hsa04744 | 0.27961618 |
| 140 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.27910458 |
| 141 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.27207597 |
| 142 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.24828086 |
| 143 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.22739227 |
| 144 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.21155732 |
| 145 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.21107086 |
| 146 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.21054853 |
| 147 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.20165338 |
| 148 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.20152087 |
| 149 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.19496400 |
| 150 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.19442466 |
| 151 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.18771662 |
| 152 | Hepatitis C_Homo sapiens_hsa05160 | 0.15694304 |
| 153 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.15647128 |

